GLG Life Tech Corporation Announces Fourth Letter of No Objection Issued by FDA for RebPure 95 Stevia Extract

GLG Life Tech Corporation

the vertically-integrated leader in the agricultural and commercial development of high quality stevia and all natural and zero calorie food and beverage products, announces the United States Food and Drug Administration has issued a Generally Recognized as Safe Letter of No Objection for GLG's high purity stevia extract, RebPure™ RA95 (Filing No. GRN000380), which contains greater than 95% Rebaudioside A and 97% of steviol glycosides. The GRAS process is a legal and FDA-approved process that allows companies to conduct their own GRAS determinations by consulting with an independent panel of scientists to determine if an ingredient meets the FDA's criteria for safety. To ensure even further confidence in its products, GLG has submitted its dossier to the FDA for review which has resulted in this Letter of No Objection.